CM
AUPH icon

Caption Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Caption Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.67M Buy
+216,363
New +$3.46M 0.02% 686
2025
Q4 		– Sell
-4,330
Closed -$61.4K – 1566
2025
Q3 		$47.8K Sell
4,330
-159,214
-97% -$1.74M ﹤0.01% 1563
2025
Q2 		$1.39M Buy
163,544
+25,392
+18% +$204K 0.02% 842
2025
Q1 		$1.11M Buy
138,152
+111,482
+418% +$903K 0.01% 878
2024
Q4 		$239K Buy
+26,670
New +$218K ﹤0.01% 1244
2024
Q3 		– Sell
-6,076
Closed -$37.7K – 1269
2024
Q2 		$34.7K Buy
+6,076
New +$32K ﹤0.01% 1075
2024
Q1 		– Sell
-114,200
Closed -$1.03M – 1197
2023
Q4 		$1.03M Buy
114,200
+81,000
+244% +$667K 0.01% 799
2023
Q3 		$258K Buy
+33,200
New +$325K ﹤0.01% 1061
2023
Q1 		– Sell
-21,900
Closed -$193K – 1084
2022
Q4 		$94.6K Sell
21,900
-36,100
-62% -$209K ﹤0.01% 1135
2022
Q3 		$436K Buy
58,000
+43,678
+305% +$378K 0.01% 1096
2022
Q2 		$144K Sell
14,322
-31,967
-69% -$357K ﹤0.01% 1266
2022
Q1 		$574K Sell
46,289
-27,166
-37% -$420K 0.01% 1113
2021
Q4 		$1.68M Buy
+73,455
New +$1.74M 0.02% 849
2021
Q2 		– Sell
-19,500
Closed -$248K – 1286
2021
Q1 		$253K Sell
19,500
-95,500
-83% -$1.39M 0.01% 893
2020
Q4 		$1.59M Hold
115,000
– – 0.04% 499
2020
Q3 		$1.69M Sell
115,000
-32,657
-22% -$473K 0.04% 488
2020
Q2 		$2.4M Buy
147,657
+113,457
+332% +$1.82M 0.08% 331
2020
Q1 		$497K Buy
34,200
+9,200
+37% +$162K 0.03% 544
2019
Q4 		$506K Buy
+25,000
New +$230K 0.02% 623

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caption Management's AUPH Position: Q2 2026 in Review

Caption Management opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 216,363 shares worth $3.67M. The stake represents 0.02% of the portfolio and ranks #686 among its holdings. This is a return to the name: Caption Management previously reported a position in AUPH as recently as Q3 2025.

Caption Management first reported a position in AUPH in Q4 2019 and has held it in 19 quarters since. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Caption Management held 216,363 shares of Aurinia Pharmaceuticals worth $3.67M as of Q2 2026.
  • Aurinia Pharmaceuticals was a new Caption Management position in Q2 2026.
  • Aurinia Pharmaceuticals made up 0.02% of Caption Management's portfolio in Q2 2026, its #686 holding.
  • Caption Management first reported a position in Aurinia Pharmaceuticals in Q4 2019 and has held it in 19 quarters since.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.